Overview Fundamentals API Earnings EOD API Sample Code Pricing

Compass Therapeutics Inc. (CMPX NASDAQ) stock market data APIs

$1.08 0(0%) as of July 26, 2024
Price chart is built with Anychart

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Compass Therapeutics Inc. Financial Data Overview

1.08
1.08
-
1.098
1
0.765-3.01
144 M
138 M
0
-0.08
0.624
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CMPX',
Type: 'Common Stock',
Name: 'Compass Therapeutics Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00LPXKF25',
ISIN: NULL,
CUSIP: NULL,
CIK: '1738021',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-04-05',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Compass Therapeutics Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -52 763 000
  • Earnings Per Share -0.35
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Compass Therapeutics Inc. Earnings via APIs

  • Latest Release 2024-05-06
  • EPS/Forecast -0.0933

Get Compass Therapeutics Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com